CD274 and ovarian cancer: In recent years, immunotherapy has also become auxiliary therapeutic treatment for advanced and recurrent ovarian cancer, including a variety of vaccines, monoconal antibodies (bevacizumab, Cediranib), immune checkpoint inhibitors for PD1/PDL1 axis and related cytokines [56].